tirzepatide retatrutide vs. Tirzepatide: The New Contender vs. the Current Leader Tirzepatide vs Retatrutide for Weight

If your patient has documented ty...

The surprising result for a GLP-1 pill (orforglipron) is the magnitude of weight loss in a Phase 3 trial of participants with Type 2 diabetes

Diabetes GLP-1s perform better but still leak demand: Diabetes-indicated GLP-1s show higher retention (24% at one year) and face fewer access hurdles due to broader coverage and disease framing, yet 76% of demand remains unmet

{eople seeking better weight management strategies, for whom GLP-1 drugs like Wegovy alone do not work, may benefit more from a combination treatment, a recent review of the evidence suggests.

Hence, further studies are warranted to decipher the mechanisms

Lake City, FL